ABCC1 and cancer: Mir-1207-5p normally targets ATP-binding cassette subfamily C member 1 (ABCC1), a well-established mediator of multidrug resistance by introducing efflux pumps to cancer cells, to reduce its effect in chemoresistance development [65].